Related Experiment Video

Updated: Dec 16, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K

A Comprehensive Analysis of Clinical Trials in the COVID-19 Pandemic Era

Jinhee Lee1, Han Wul Shin2, Jun Young Lee2

  • 1Department of Psychiatry, Yonsei University, Wonju College of Medicine, Wonju Kangwon 26426, Korea.

Medicina (Kaunas, Lithuania)
|July 2, 2020
PubMed

Insights

Researchers analyzed COVID-19 clinical trials registered by March 2020. Most trials focused on treatments, investigating drugs like chloroquine and remdesivir, with many originating in China.

Area of Science:

  • * Virology and Epidemiology
  • * Clinical Trial Analysis
  • * Infectious Disease Research

Background:

  • * The COVID-19 pandemic presented a global health crisis with no established treatments or vaccines.
  • * Rapid development of clinical trials was crucial for identifying effective interventions.
  • * Learning from the COVID-19 pandemic is vital for future pandemic preparedness.

Purpose of the Study:

  • * To provide a comprehensive overview of COVID-19 clinical trials.
  • * To analyze the landscape of registered studies in the ClinicalTrials.gov database.
  • * To identify key therapeutic agents under investigation.

Main Methods:

  • * Systematic review of clinical trials registered up to March 30, 2020.
  • * Identification and analysis of 147 eligible COVID-19 clinical trials.
  • * Overview of study designs and therapeutic interventions.

Main Results:

  • * The majority of COVID-19 clinical trials were initiated in China.
  • * Treatment approaches were the primary focus of registered studies.
  • * Investigational agents included chloroquine, interferon, remdesivir, lopinavir, and ritonavir.

Conclusions:

  • * The study highlights promising therapeutic options explored during the early COVID-19 pandemic.
  • * Identified key drugs and treatment strategies under investigation.
  • * Aims to address underlying challenges within COVID-19 clinical trials.
Keywords:
COVID-19clinical trials

More Related Videos

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-1908:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.2K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-208:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.2K

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
316
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
746
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
462
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
572